business

Candel reports extended phase 3 prostate cancer trial results

Investing.com · May 15, 2026, 8:13 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Regenxbio Shares Rise After Positive Duchenne Trial Results Yahoo Finance Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026 STAT News PSA screening for prostate cancer reduces disease-specific deaths, new review shows

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Candel reports extended phase 3 prostate cancer trial results

Also covered by

More in business